---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-018098"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2026-05-21T20:23:32+00:00"
generated_at: "2026-05-21T20:24:18.426093+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical publishes clinical data showing 81.8% cellulite improvement with Avéli-Renuvion combination

## Summary
- 22 patients received single-session treatment combining Avéli subcision and Renuvion helium plasma RF.
- Up to 81.8% of patients showed improvement in cellulite appearance at 180 days post-treatment.
- 3D imaging confirmed measurable reductions in dimple volume, surface area, and depth.
- Histological analysis in a subset showed increased collagen and elastin with progressive tissue remodeling.
- Study published in Aesthetic Surgery Journal Open Forum; supports combined approach for cellulite and skin laxity.

## SEC filing metadata
- accession: 0001437749-26-018098
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2026-05-21T20:23:32+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000143774926018098/0001437749-26-018098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000143774926018098/apyx20260521_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-018098
- JSON: https://secwatch.observer/filing/0001437749-26-018098.json
- Plain text: https://secwatch.observer/filing/0001437749-26-018098.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.